Detalhe da pesquisa
1.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med
; 390(15): 1359-1371, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631003
2.
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
Oncologist
; 29(2): 142-150, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589219
3.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med
; 385(8): 683-694, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407342
4.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(9): 1133-1144, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055304
5.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
6.
Day-case robotic-assisted partial nephrectomy: feasibility and preliminary results of a prospective evaluation (UroCCR-25 AMBU-REIN study).
World J Urol
; 40(6): 1351-1357, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32514670
7.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
N Engl J Med
; 379(5): 417-427, 2018 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860937
8.
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
BMC Med Res Methodol
; 21(1): 95, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933001
9.
The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours.
Acta Oncol
; 60(12): 1597-1603, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34549686
10.
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Pharm Res
; 37(7): 147, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676789
11.
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience.
BMC Cancer
; 19(1): 1182, 2019 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31795959
12.
Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study.
BJU Int
; 123(5): 804-810, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288884
13.
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring.
Ther Drug Monit
; 41(1): 66-74, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30299429
14.
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma.
Br J Cancer
; 119(6): 663-669, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30197417
15.
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.
Ann Rheum Dis
; 77(3): 393-398, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146737
16.
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
BMC Cancer
; 17(1): 323, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28494780
17.
Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.
Pharmacoepidemiol Drug Saf
; 26(12): 1561-1569, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28573786
18.
Prognostic factors for cancer patient admitted to a medical intensive care unit.
Acta Oncol
; 59(4): 458-461, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948319
19.
Testicular-sparing surgery for bilateral or monorchide testicular tumours: a multicenter study of long-term oncological and functional results.
BJU Int
; 114(6): 860-4, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24180380
20.
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma.
Cancers (Basel)
; 16(9)2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730732